Schedule 13G ownership disclosure
BioLife Solutions Inc
COMMON STOCK · CUSIP: 09062W204
Event date: 2025-12-31
- Filing-level shares
- 5,180,824
- Percent of class
- 10.8%
- T. Rowe Price Investment Management, Inc.
Shares: 5,180,824 · Class: 10.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001897612-26-000006
- Form type
- SCHEDULE 13G/A
- Filer
- BIOLIFE SOLUTIONS INC
- CIK
- CIK 834365
- Filed
- Jan 08, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership